Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Public ClinicalTrials.gov record NCT00116675. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for 4 Weeks for the Treatment of Common Warts in Pediatric Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the effectiveness in pediatric subjects of three different strengths of resiquimod gel applied to common wart(s) three times a week for four weeks. A second purpose is to evaluate the safety of the drug.
Study identification
- NCT ID
- NCT00116675
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 84 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2005
- Primary completion
- Not listed
- Completion
- Mar 31, 2006
- Last update posted
- Feb 18, 2007
2005 – 2006
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Clinic of Jonesboro, PA | Jonesboro | Arkansas | 72401 | — |
| University of California - San Francisco | San Francisco | California | 94143 | — |
| Longmont Clinic/Longmont Medical Research Network | Longmont | Colorado | 80501 | — |
| Mercy Health Research | St Louis | Missouri | 63141 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Rhode Island Hospital - Jane Brown Building | Providence | Rhode Island | 02903 | — |
| DermResearch, Inc. | Austin | Texas | 78759 | — |
| Alpine Pediatrics | Pleasant Grove | Utah | 84062 | — |
| Walla Walla Clinic | Walla Walla | Washington | 99362 | — |
| Advanced Healthcare | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Warts trials
Other public records listing Warts. Sorted by last update posted; newest first. Not a recommendation.
- NCT07775313: Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM Not yet recruiting
- NCT07637734: Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) Not yet recruiting
- NCT00967785: A Phase I Study of Mozobil in the Treatment of Patients With WHIMS Recruiting
- NCT00867269: Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia Recruiting
- NCT07457918: Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris) Recruiting
- NCT07246590: Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00116675, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2007 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00116675 live on ClinicalTrials.gov.